ENTITY

Dogwood Therapeutics (DWTX US)

11
Analysis
Health Care • United States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
Company Event • 07 Mar 2026 01:30 • Upcoming
Add To Calendar
Company Event • 21 Nov 2025 23:00 • Latest
Company Event • 06 Nov 2025 20:00 • Upcoming
Add To Calendar
Company Event • 29 Sep 2025 20:30
Company Event • 13 Aug 2025 21:30 • Upcoming
Add To Calendar
x